News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EssilorLuxottica: Essilor Stellest est le tout premier verre optique à recevoir de la FDA une autorisation de mise sur le marché aux États-Unis
EssilorLuxottica obtient l'autorisation de la FDA pour le verre Essilor Stellest, unique pour ralentir la myopie chez les enfants. Étude clinique démontre un ralentissement de 71% sur 2 ans -
COMMUNIQUÉ DE PRESSE
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica's Essilor Stellest lens, the first FDA market authorized spectacle lens in the U.S., clinically proven to slow myopia progression in children, with 71% effectiveness over 2 years -
-
-
COMMUNIQUÉ DE PRESSE
EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future
EssilorLuxottica and Meta showcase new AI glasses at Meta Connect, including Oakley Meta Vanguard for athletes, Ray-Ban Meta Gen 2 with extended battery life, and Meta Ray-Ban Display with integrated display
